Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Alterity Therapeutics Limited ATHE
$2.77
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
11578660.00000000
-
week52high
8.50
-
week52low
2.52
-
Revenue
7844799
-
P/E TTM
-3817
-
Beta
0.85839600
-
EPS
-2.32000000
-
Last Dividend
0.00000000
-
Next Earnings Date
07 мая 2023 г. в 02:48
Описание компании
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Ladenburg Thalmann | Buy | 03 авг 2022 г. | |
| Goldman Sachs | Neutral | Neutral | 23 июн 2022 г. |
| Benchmark | Speculative Buy | 20 авг 2021 г. | |
| B. Riley FBR | Buy | Buy | 05 янв 2018 г. |
| MLV & Co. | Hold | Buy | 31 мар 2014 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии